^
    2years
    Improving the performance of early breast cancer diagnosis by a model combining breast ultrasound with methylation markers in non-invasive circulating tumor DNA (SABCS 2022)
    Itimproves the diagnostic accuracy of the indeterminate breast nodules, which may assist indecreasing the unnecessary biopsies or surgeries of patients with benign lesions. Themethylation model also has the potential in predicting metastatic and non-metastatic breastcancers that is valuable for patient surveillance and risk prediction.
    Circulating tumor DNA
    |
    AnchorIRIS™